Vanderbilt University Medical Center is set to construct a state-of-the-art BioSafety Level 3 (BSL3) facility for research involving the COVID-19 virus, anthrax and other dangerous microorganisms.

Efforts to correct mistaken or outdated penicillin allergy records are destined to spread to more patient care areas at Vanderbilt University Medical Center.

Vanderbilt reseach shows that resources for lung cancer screening programs increased the number of veterans screened.

Vanderbilt Translational Research Forum, an annual celebration of the “translation” of scientific discovery into clinical practice, will be held Oct. 21 at the Vanderbilt University Student Life Center.

Vanderbilt has been recognized as a National Pancreas Foundation Center of Excellence.

REDCap administrators from around the world recently attended the 14th edition of REDCapCon in Boston, hosted this year by Harvard Catalyst, Harvard University’s center for clinical and translational science.

Vanderbilt research shows that higher reimbursement from the Centers for Medicare & Medicaid Services was not associated with wider use of an embolic protection device during transcatheter aortic valve replacement procedures.